OAR 415-020-0010
Program Approval
(1)
Letter of Approval: No person or governmental entity shall operate an Opioid Treatment Program without a letter of approval from the State Methadone Authority in Oregon.(2)
Application: To receive a certificate for the provision of behavioral health treatment services an Opioid Treatment Program must meet the criteria under OAR 309-008-0100 (Purpose and Scope) to 309-008-1600 (Variance); in addition, the Opioid Treatment Program must:(a)
Meet the standards set forth in these rules and any other administrative rules applicable to the program;(b)
Comply with the federal regulations contained in 42 CFR Part 2 and 42 CFR Part 8; and(c)
Submit documentation of accreditation as an opioid treatment program by an accreditation body approved by SAMHSA under 42 CFR Part 8.(d)
Specify in the application the identity and financial interest of any person (if the person is a corporation, the name of any stockholder holding stock representing an interest of 5 percent or more) or other legal entity who has an interest of 5 percent or more or 5 percent of a lease agreement for the facility.(3)
Renewal: The renewal of a Certificate shall be governed by OAR 309-008-0100 (Purpose and Scope) to 309-008-1600 (Variance).(4)
Denial, Revocation, Nonrenewal, Suspension: The denial, revocation, nonrenewal, or suspension of a letter of approval or license for an opioid treatment program may be based on any of the grounds set forth in OAR 309-008-1100 (Nonrenewal, Suspension, and Revocation of Certification).(5)
Federal Protocols: The program shall be responsible for filing and maintaining all necessary protocols and documentation required by the National Institute on Drug Abuse (NIDA), the Federal Substance Abuse and Mental Health Services Administration, and the Federal Drug Enforcement Administration.
Source:
Rule 415-020-0010 — Program Approval, https://secure.sos.state.or.us/oard/view.action?ruleNumber=415-020-0010.